dc.contributor.author
Barleben, Luisa
dc.contributor.author
Simon, Mareike
dc.contributor.author
Drees, Lisa
dc.contributor.author
Flohr, Franziska
dc.contributor.author
Jochum, Christoph
dc.contributor.author
Di Virgilio, Michela
dc.contributor.author
Tacke, Frank
dc.contributor.author
Bröer, Sonja
dc.contributor.author
Wolf, Jana
dc.contributor.author
Kolesnichenko, Marina
dc.date.accessioned
2026-01-05T12:53:43Z
dc.date.available
2026-01-05T12:53:43Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/50927
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50654
dc.description.abstract
Effective pain management in animal models is crucial for maintaining ethical and scientific integrity. However, commonly used analgesics may affect immune responses and disturb signaling pathways, thereby potentially confounding the experimental outcomes. In mouse colitis models, opioids and non-steroidal anti-inflammatory drugs have been shown to interfere with the immune response and the activation of the central regulator of inflammation, the transcription factor nuclear factor kappa B (NF-κB). Here, we propose a tailored pipeline for the identification and the validation of analgesics with minimal off-target effects. This approach combines protein-centered relation extraction using deep language models and distant supervision via the Protein-Centered Association Extraction with Deep Language (PEDL + ) together with an in vivo experimental validation with a NF-κB reporter mouse model that enables unambiguous visualization of direct NF-κB activity across different tissues. Our findings indicate that commonly used analgesics, such as tramadol and acetaminophen, not only interfere with immune cell recruitment and NF-κB activation but also skew the differentiation of epithelial stem cells into goblet cells, affecting epithelial functions even after short exposures. Conversely, the analgesics selected by our PEDL + -based workflow, such as piritramide, demonstrated no significant interference with NF-κB signaling. To validate our findings in vivo , we treated our NF-κB reporter mice with the analgesics selected by our computational pipeline. Amantadine demonstrated the least impact on the inflammatory responses and NF-κB activation. We then predicted and identified the signaling pathways that are impacted by amantadine treatment. In summary, our proposed pipeline facilitates a shift from one-size-fits-all analgesics to a precision medicine approach that considers the unique molecular interactions associated with each model.
dc.format.extent
15 Seiten
dc.rights
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
NF-κB signaling
en
dc.subject
deep language
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::630 Landwirtschaft::630 Landwirtschaft und verwandte Bereiche
dc.title
Deep learning, deeper relief: pipeline toward tailored analgesia for experimental animal models
dc.type
Wissenschaftlicher Artikel
dc.date.updated
2025-12-30T10:14:13Z
dcterms.bibliographicCitation.articlenumber
1639881
dcterms.bibliographicCitation.doi
10.3389/fimmu.2025.1639881
dcterms.bibliographicCitation.journaltitle
Frontiers in Immunology
dcterms.bibliographicCitation.volume
16
dcterms.bibliographicCitation.url
https://doi.org/10.3389/fimmu.2025.1639881
refubium.affiliation
Veterinärmedizin
refubium.affiliation.other
Institut für Pharmakologie und Toxikologie

refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1664-3224
refubium.resourceType.provider
DeepGreen